NCA
ORGO icon

New Century Advisors’s Organogenesis Holdings ORGO Stock Holding History

New Century Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$5K Buy
+1,401
New +$6.33K 0.01% 100

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

New Century Advisors's ORGO Position: Q3 2022 in Review

New Century Advisors opened a new position in Organogenesis Holdings (ORGO) in Q3 2022: 1,401 shares worth $5K. The stake represents 0.01% of the portfolio and ranks #100 among its holdings.

154 funds tracked by Wall St. Rank hold ORGO as of Q3 2022.

  • New Century Advisors held 1,401 shares of Organogenesis Holdings worth $5K as of Q3 2022.
  • Organogenesis Holdings was a new New Century Advisors position in Q3 2022.
  • Organogenesis Holdings made up 0.01% of New Century Advisors's portfolio in Q3 2022, its #100 holding.
  • 154 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2022.

Based on New Century Advisors's 13F filing for Q3 2022, filed 13 Oct 2022.